亚洲日韩欧美综合-亚洲日韩欧美一区二区在线-亚洲日韩欧美视频-亚洲日韩精品欧美一区二区-国产欧美日韩综合

會(huì)員登錄|免費(fèi)注冊(cè)|忘記密碼|管理入口 返回主站||保存桌面|手機(jī)瀏覽|聯(lián)系方式|購(gòu)物車(chē)
企業(yè)會(huì)員第1年

成都云希化工有限公司  

美容肽,多肽,美容原料,定制肽,醫(yī)藥中間體

搜索
新聞中心
  • 暫無(wú)新聞
產(chǎn)品分類(lèi)
聯(lián)系方式
  • 聯(lián)系人:陳
  • 電話(huà):19150309904
  • 郵件:aileen@youngshechem.com
  • 微信:19150309904
  • QQ:1398029096
站內(nèi)搜索
 
榮譽(yù)資質(zhì)
  • 暫未上傳
友情鏈接
  • 暫無(wú)鏈接
首頁(yè) > 供應(yīng)產(chǎn)品 > Bradykinin Acetate血管緩激肽
Bradykinin Acetate血管緩激肽
單價(jià) 10.00 / g對(duì)比
銷(xiāo)量 暫無(wú)
發(fā)貨 四川成都市付款后3天內(nèi)
庫(kù)存 10000g起訂1g
CAS號(hào) 5979-11-3
過(guò)期 長(zhǎng)期有效
更新 2021-07-21 15:06
 
詳細(xì)信息

Bradykinin Acetate

1.Basic information:

Name: Bradykinin Acetate

Synonym:BK;L-Bradykinin;Callidin I;CallidinI;Callidin-I;KallidinI;Kallidin I;Kallidin-I;C acid;C-acid;Kallidin 9;Kallidin-9;Kallidin9;Bradykinin

Cas No: 5979-11-3

Formula: C50H73N15O11

Molecular: 1060.22

Sequence: H-Arg-Pro-Pro-Gly-Phe-Ser-Pro-Phe-Arg-OH acetate salt

Purity:98%

Appearance: white powder

MSDS and COA: available for your reference

Source: synthetic


 

產(chǎn)品參數(shù):

 

INCI名稱(chēng):血管緩激肽

形狀:白色粉末

PH:無(wú)

純度:95%

儲(chǔ)存條件:2~8℃密封避光儲(chǔ)存,長(zhǎng)期存儲(chǔ)建議零下15~20℃冷藏最佳

安全性:無(wú)重金屬,無(wú)皮膚及眼刺激

包裝規(guī)格:1/

注意:本品為科研原料,不建議用于人體

©2025 成都云希化工有限公司 版權(quán)所有   技術(shù)支持:化工網(wǎng)   訪(fǎng)問(wèn)量:41624  
 
主站蜘蛛池模板: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |